Cite
Average treatment effect of facility hepatopancreatobiliary cancer volume on survival of non-resected pancreatic adenocarcinoma.
MLA
Elshami, Mohamedraed, et al. “Average Treatment Effect of Facility Hepatopancreatobiliary Cancer Volume on Survival of Non-Resected Pancreatic Adenocarcinoma.” HPB : The Official Journal of the International Hepato Pancreato Biliary Association, vol. 24, no. 11, Nov. 2022, pp. 1878–87. EBSCOhost, https://doi.org/10.1016/j.hpb.2022.07.007.
APA
Elshami, M., Ahmed, F. A., Kakish, H., Hue, J. J., Hoehn, R. S., Rothermel, L. D., Bajor, D., Mohamed, A., Selfridge, J. E., Ammori, J. B., Hardacre, J. M., Winter, J. M., & Ocuin, L. M. (2022). Average treatment effect of facility hepatopancreatobiliary cancer volume on survival of non-resected pancreatic adenocarcinoma. HPB : The Official Journal of the International Hepato Pancreato Biliary Association, 24(11), 1878–1887. https://doi.org/10.1016/j.hpb.2022.07.007
Chicago
Elshami, Mohamedraed, Fasih A Ahmed, Hanna Kakish, Jonathan J Hue, Richard S Hoehn, Luke D Rothermel, David Bajor, et al. 2022. “Average Treatment Effect of Facility Hepatopancreatobiliary Cancer Volume on Survival of Non-Resected Pancreatic Adenocarcinoma.” HPB : The Official Journal of the International Hepato Pancreato Biliary Association 24 (11): 1878–87. doi:10.1016/j.hpb.2022.07.007.